Whole Genomic Analysis Revealed High Genetic Diversity and Drug-Resistant Characteristics of Mycobacterium tuberculosis in Guangxi, China

References

• World Health Organization. Global tuberculosis report 2021. Geneva: World Health Organization; 2021.
   Google Scholar
• Freschi L, Vargas R, Husain A, et al. Population structure, biogeography and transmissibility of Mycobacterium tuberculosis. Nat Commun. 2021;12(1):6099. doi:10.1038/s41467-021-26248-1
   PubMed Web of Science ®Google Scholar
• Liu Q, Ma A, Wei L, et al. China’s tuberculosis epidemic stems from historical expansion of four strains of Mycobacterium tuberculosis. Nat Ecol Evol. 2018;2(12):1982–1992. doi:10.1038/s41559-018-0680-6
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis report 2022. Geneva; 2022.
   Google Scholar
• Allix-Béguec C, Arandjelovic I, Bi L, et al. Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing. N Engl J Med. 2018;379(15):1403–1415. doi:10.1056/NEJMoa1800474
   PubMed Web of Science ®Google Scholar
• Pankhurst LJ, Del Ojo Elias C, Votintseva AA, et al. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Respir Med. 2016;4(1):49–58. doi:10.1016/s2213-2600(15)00466-x
   PubMed Web of Science ®Google Scholar
• Rivière E, Heupink TH, Ismail N, et al. Capacity building for whole genome sequencing of Mycobacterium tuberculosis and bioinformatics in high TB burden countries. Brief Bioinform. 2021;22(4). doi:10.1093/bib/bbaa246
   PubMed Web of Science ®Google Scholar
• Tagliani E, Anthony R, Kohl TA, et al. Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017–2019: an ECDC pilot study. Eur Respir J. 2021;57(1). doi:10.1183/13993003.02272-2020
   Web of Science ®Google Scholar
• Papaventsis D, Casali N, Kontsevaya I, Drobniewski F, Cirillo DM, Nikolayevskyy V. Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review. Clin Microbiol Infect. 2017;23(2):61–68. doi:10.1016/j.cmi.2016.09.008
   PubMed Web of Science ®Google Scholar
• Lin D, Cui Z, Chongsuvivatwong V, et al. The geno-spatio analysis of Mycobacterium tuberculosis complex in hot and cold spots of Guangxi, China. BMC Infect Dis. 2020;20(1):462. doi:10.1186/s12879-020-05189-y
   PubMedGoogle Scholar
• Lin D, Wang J, Cui Z, Ou J, Huang L, Wang Y. A genome epidemiological study of mycobacterium tuberculosis in subpopulations with high and low incidence rate in Guangxi, South China. BMC Infect Dis. 2021;21(1):840. doi:10.1186/s12879-021-06385-0
   PubMed Web of Science ®Google Scholar
• Rastogi N, Goh KS, David HL. Drug susceptibility testing in tuberculosis: a comparison of the proportion methods using Lowenstein-Jensen, Middlebrook 7H10 and 7H11 agar media and a radiometric method. Res Microbiol. 1989;140(6):405–417. doi:10.1016/0923-2508(89)90016-8
   PubMed Web of Science ®Google Scholar
• Larsen MH, Biermann K, Tandberg S, Hsu T, Jacobs WR. Genetic manipulation of Mycobacterium tuberculosis. Curr Protoc Microbiol. 2007. doi:10.1002/9780471729259.mc10a02s6
   Google Scholar
• Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–2120. doi:10.1093/bioinformatics/btu170
   PubMed Web of Science ®Google Scholar
• Phelan JE, O’Sullivan DM, Machado D, et al. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs. Genome Med. 2019;11(1):41. doi:10.1186/s13073-019-0650-x
   PubMed Web of Science ®Google Scholar
• Coll F, McNerney R, Guerra-Assunção JA, et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun. 2014;5:4812. doi:10.1038/ncomms5812
   PubMed Web of Science ®Google Scholar
• Shitikov E, Kolchenko S, Mokrousov I, et al. Evolutionary pathway analysis and unified classification of East Asian lineage of Mycobacterium tuberculosis. Sci Rep. 2017;7(1):9227. doi:10.1038/s41598-017-10018-5
   PubMed Web of Science ®Google Scholar
• Meehan CJ, Moris P, Kohl TA, et al. The relationship between transmission time and clustering methods in Mycobacterium tuberculosis epidemiology. EBioMedicine. 2018;37:410–416. doi:10.1016/j.ebiom.2018.10.013
   PubMed Web of Science ®Google Scholar
• Srilohasin P, Prammananan T, Faksri K, et al. Genomic evidence supporting the clonal expansion of extensively drug-resistant tuberculosis bacteria belonging to a rare proto-Beijing genotype. Emerg Microbes Infect. 2020;9(1):2632–2641. doi:10.1080/22221751.2020.1852891
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment; 2019.
   Google Scholar
• Liu M, Xu P, Liao X, et al. Molecular epidemiology and drug-resistance of tuberculosis in Luodian revealed by whole genome sequencing. Infect Genet Evol. 2021;93:104979. doi:10.1016/j.meegid.2021.104979
   PubMed Web of Science ®Google Scholar
• Li Q, Wang Y, Li Y, et al. Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China. J Glob Antimicrob Resist. 2019;18:168–176. doi:10.1016/j.jgar.2019.03.012
   PubMed Web of Science ®Google Scholar
• Jiang Q, Liu Q, Ji L, et al. Citywide transmission of multidrug-resistant tuberculosis under China’s rapid urbanization: a retrospective population-based genomic spatial epidemiological study. Clin Infect Dis. 2020;71(1):142–151. doi:10.1093/cid/ciz790
   PubMed Web of Science ®Google Scholar
• Liu Q, Liu H, Shi L, et al. Local adaptation of Mycobacterium tuberculosis on the Tibetan Plateau. Proc Natl Acad Sci U S A. 2021;118(17). doi:10.1073/pnas.2017831118
   Web of Science ®Google Scholar
• Holt KE, McAdam P, Thai PVK, et al. Frequent transmission of the Mycobacterium tuberculosis Beijing lineage and positive selection for the EsxW Beijing variant in Vietnam. Nat Genet. 2018;50(6):849–856. doi:10.1038/s41588-018-0117-9
   PubMed Web of Science ®Google Scholar
• Cox HS, Kubica T, Doshetov D, Kebede Y, Rüsch-Gerdess S, Niemann S. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia. Respir Res. 2005;6(1):134. doi:10.1186/1465-9921-6-134
   PubMedGoogle Scholar
• Zhao LL, Li MC, Liu HC, et al. Beijing genotype of Mycobacterium tuberculosis is less associated with drug resistance in south China. Int J Antimicrob Agents. 2019;54(6):766–770. doi:10.1016/j.ijantimicag.2019.08.005
   PubMed Web of Science ®Google Scholar
• Yang C, Shen X, Peng Y, et al. Transmission of Mycobacterium tuberculosis in China: a population-based molecular epidemiologic study. Clin Infect Dis. 2015;61(2):219–227. doi:10.1093/cid/civ255
   PubMed Web of Science ®Google Scholar
• Dean AS, Zignol M, Cabibbe AM, et al. Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: a multicountry analysis of cross-sectional data. PLoS Med. 2020;17(1):e1003008. doi:10.1371/journal.pmed.1003008
   PubMed Web of Science ®Google Scholar
• Dookie N, Rambaran S, Padayatchi N, Mahomed S, Naidoo K. Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care. J Antimicrob Chemother. 2018;73(5):1138–1151. doi:10.1093/jac/dkx506
   PubMed Web of Science ®Google Scholar
• Shea J, Halse TA, Kohlerschmidt D, et al. Low-level rifampin resistance and rpoB mutations in mycobacterium tuberculosis: an analysis of whole-genome sequencing and drug susceptibility test data in New York. J Clin Microbiol. 2021;59(4). doi:10.1128/JCM.01885-20
   PubMed Web of Science ®Google Scholar
• He W, Tan Y, Liu C, et al. Drug-resistant characteristics, genetic diversity, and transmission dynamics of rifampicin-resistant Mycobacterium tuberculosis in Hunan, China, revealed by whole-genome sequencing. Microbiol Spectr. 2022;10(1):e0154321. doi:10.1128/spectrum.01543-21
   PubMed Web of Science ®Google Scholar
• Ma P, Luo T, Ge L, et al. Compensatory effects of M. tuberculosis rpoB mutations outside the rifampicin resistance-determining region. Emerg Microbes Infect. 2021;10(1):743–752. doi:10.1080/22221751.2021.1908096
   PubMed Web of Science ®Google Scholar
• Safi H, Fleischmann RD, Peterson SN, Jones MB, Jarrahi B, Alland D. Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2010;54(1):103–108. doi:10.1128/aac.01288-09
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Q, Gao H, et al. The roles of rpsL, rrs, and gidB mutations in predicting streptomycin-resistant drugs used on clinical Mycobacterium tuberculosis isolates from Hebei Province, China. Int J Clin Exp Pathol. 2019;12(7):2713–2721.
   PubMed Web of Science ®Google Scholar
• Gomes LC, Campino S, Marinho CRF, Clark TG, Phelan JE. Whole genome sequencing reveals large deletions and other loss of function mutations in Mycobacterium tuberculosis drug resistance genes. Microb Genom. 2021;7(12). doi:10.1099/mgen.0.000724
   Google Scholar
• Vaziri F, Kohl TA, Ghajavand H, et al. Genetic diversity of multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in the capital of Iran, revealed by whole-genome sequencing. J Clin Microbiol. 2019;57(1). doi:10.1128/jcm.01477-18
   PubMed Web of Science ®Google Scholar
• Louw GE, Warren RM, Gey van Pittius NC, McEvoy CR, Van Helden PD, Victor TC. A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob Agents Chemother. 2009;53(8):3181–3189. doi:10.1128/aac.01577-08
   PubMed Web of Science ®Google Scholar
• Nonghanphithak D, Chaiprasert A, Smithtikarn S, et al. Clusters of drug-resistant mycobacterium tuberculosis detected by whole-genome sequence analysis of nationwide sample, Thailand, 2014–2017. Emerg Infect Dis. 2021;27(3):813–822. doi:10.3201/eid2703.204364
   PubMed Web of Science ®Google Scholar